Heather Hartnett
Founder & CEO @ Human Ventures
New York, United States
Heather Hartnett is a seed investor at Human Ventures in New York focused on Software and Marketing. Heather Hartnett is the Founder and CEO of Human Ventures. She previously worked at AARP as an Innovators Council Member. Heather Hartnett attended New York University.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Heather Hartnett invests in
Stages Heather Hartnett invests in
Countries Heather Hartnett invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 3 (25%)
- Marketing 3 (25%)
- Health Care 2 (17%)
- Artificial Intelligence 2 (17%)
- NFC 1 (8%)
Stage
- Seed 7 (58%)
- Pre-Seed 1 (8%)
- Series A 1 (8%)
- Series B 1 (8%)
- Funding Round 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Breakaway Music Festival is a performing arts company of pop, dance, and hip-hop music festival series. Breakaway Music Festival hosts college students and young professionals annually, touring college campuses across the US, and activating a small army of college student ambassadors. Founded by Adam Lynn in 2016 and is located in Columbus,Ohio. | $48.9M / Series B / Mar 12, 2026 | ||
| Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | ||
| Honeyjar is the AI platform for PR teams, agencies, and marketing and communications leaders. Designed by comms professionals, Honeyjar expertly runs the entire workflow while bringing news, social, and all the critical data for comms into one intelligent, centralized workspace. | $2M / Pre-Seed / Dec 04, 2025 | ||
| Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $4.7M / Seed / Feb 10, 2025 | ||
| Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $5M / Seed / Feb 29, 2024 | ||
| Founded in 2021 by Champ Bennett and Joseph Jorgensen, Capsule is designed to help businesses meet the growing demand for video. Built with CapsuleScript, a first-of-its-kind markup language for video that automates video post-production and makes desktop-quality video possible from any device with a browser, Capsule makes it easy to crowdsource,edit and distribute video. Try it at Capsule.video.Capsule has raised funding from top investors in the AI and creative tools space, including Array Ventures, Bloomberg Beta, Swift Ventures, Clark Valberg (Founder of InVision), Amjad Masad (CEO, Replit), Arash Ferdowsi (CTO, Dropbox), Kyle Parrish (Head of Sales, Figma), Mike Mignano (ex-Head of Audio & Video, Spotify), Roy Raanani (Co-Founder, Chorus.ai) and Sahil Lavingia (Founder, Gumroad). | $5.7M / Seed / Feb 14, 2023 | ||
| Adelaide develops a media analytics platform to measure omnichannel media quality. It specializes in measurement and digital ad-buying analytics and offers an omnichannel media quality score that measures attention for media planning and buying. | $7M / Seed / Jun 02, 2022 | ||
| Glow Labs is a no-code loyalty rewards program built on the blockchain. Glow Labs is a white-label loyalty rewards program on the blockchain built by the community for the community. It was founded and led by two engineers in their twenties—Annie Reardon and Renee Russo—in 2021, and is based in Portsmouth, New Hampshire, United States. | $4.2M / Seed / Apr 12, 2022 | ||
| Shift One is a marketplace for skilled labor in warehouse, logistics, and assembly. The company was founded in 2018 and is headquartered in San Francisco, California. | $3M / Seed / Aug 12, 2021 | ||
| Movo is a technology company with two products serving different markets. Movo Presence is the company's primary product and current go-to-market focus. It is a multi-signal presence verification platform for healthcare compliance. Current Electronic Visit Verification (EVV) systems, mandated under the 21st Century Cures Act, capture twotimestamps: clock-in and clock-out. Everything between those timestamps is unverified. GPS-based verification is probabilistic, fails indoors, and produces match rates below 60% for personal care and as low as 11% for home health services. Movo fills this gap with continuous, hardware-anchored verification using NFC tap-in/tap-out, BLE continuous presence monitoring, motion analysis, device integrity attestation, and more than 30 proprietary anti-fraud algorithms running on every visit. Each visit produces a Visit Evidence Record: a tamper-proof, SHA-256 sealed, PDF/A-3 attestation certificate that serves as standalone, audit-grade proof a visit occurred. No integration with existing EVV vendors, EMR systems, or payroll platforms is required. NFC tags cost under $1 and deploy in days. Movo Frontline is an autonomous workforce management platform serving over 700,000 daily users across logistics, healthcare, manufacturing, and hospitality. Unlike legacy WFM suites that publish static schedules, Movo Frontline uses reinforcement learning to rebalance rosters every 30-60 seconds, routes tasks algorithmically, and resolves 80-90% of workforce exceptions (call outs, early departures, compliance flags) without manager intervention. Measured results include 23-30% labor productivity gains, 20-40% overtime reduction, and $2,000-$3,000 per year EBITDA lift per frontline worker. Pricing is $3-$5 per employee per month, compared to $27-$37 PEPM for legacy enterprise WFM platforms. Movo is headquartered in San Francisco, California with offices in Edina, Minnesota. Founded in 2019 by Jason Radisson, a former McKinsey engagement manager, West Coast RGM at Uber, and COO of 99 (sold to DiDi for $1 billion). Jason is a board trustee at American Public Media Group and Minnesota Public Radio and hosts the CEO Tradecraft podcast. | $3M / Seed / Aug 12, 2021 | ||
| See all 12 investments → | |||
Co-Investors
About Human Ventures
Human Ventures is a fund and partner in New York City. They possess their own perspective on evaluating companies due to their experience in building businesses themselves. Consequently, Human Ventures focuses on supporting founders who are establishing category-defining companies in the pre-seed and seed stages. In terms of their investment focus,they concentrate on the Human Needs Economy, which encompasses areas such as health and wellness, the future of work and finance, the attention economy, and human connection through experiences.
Human Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chelsea Boyes
Head Of Accounting
|
|||
Elise King
Senior Associate and Investor
|
|||
|
Heather Hartnett
Founder & CEO
|
|||
Joe Marchese
Executive Chairman & Build Partner
|
|||
Melani Price
Office Manager & Head of Community
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Heather Hartnett invest in?
Heather Hartnett invests primarily in Software, Marketing and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Heather Hartnett?
Public channels for Heather Hartnett include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Heather Hartnett last invest?
The most recent investment recorded for Heather Hartnett closed in Mar 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
